tiprankstipranks
Trending News
More News >
Avenue Therapeutics (ATXI)
:ATXI
US Market

Avenue Therapeutics (ATXI) Financial Statements

Compare
331 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently $664.66K. The company's EPS TTM is $-0.732; its P/E ratio is ―; Avenue Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -11.28M$ -14.54M$ -8.04M$ -3.74M$ -5.21M
EBITDA$ -11.28M$ 4.05M$ 0.00$ 0.00$ -5.21M
Net Income$ -11.65M$ -10.38M$ 2.05M$ -3.72M$ -5.09M
Balance Sheet
Cash & Short-Term Investments$ 2.59M$ 1.78M$ 6.71M$ 3.76M$ 3.13M
Total Assets$ 2.67M$ 1.85M$ 6.84M$ 3.96M$ 3.25M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.59M$ -1.78M$ -6.71M$ -3.76M$ -3.13M
Total Liabilities$ 816.00K$ 1.20M$ 3.58M$ 509.00K$ 886.00K
Stockholders' Equity$ 2.80M$ 1.58M$ 3.90M$ 3.45M$ 2.36M
Cash Flow
Free Cash Flow$ -9.03M$ -12.45M$ -7.60M$ -3.75M$ -5.61M
Operating Cash Flow$ -9.03M$ -9.45M$ -7.60M$ -3.75M$ -4.61M
Investing Cash Flow$ 0.00$ -3.00M$ 0.00$ 0.00$ -1.00M
Financing Cash Flow$ 9.84M$ 7.53M$ 10.54M$ 4.38M$ 0.00
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Avenue Therapeutics Debt to Assets

Avenue Therapeutics Cash Flow

Avenue Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis